Marshall Sullivan Inc Wa buys $3.5 Million stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Marshall Sullivan Inc Wa scooped up 92 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 13, 2016. The investment management firm now holds a total of 31,257 shares of Stryker Corporation which is valued at $3.5 Million.Stryker Corporation makes up approximately 4.48% of Marshall Sullivan Inc Wa’s portfolio.

Other Hedge Funds, Including , Pictet Asset Management Ltd boosted its stake in SYK in the latest quarter, The investment management firm added 72,976 additional shares and now holds a total of 434,844 shares of Stryker Corporation which is valued at $48.2 Million. Stryker Corporation makes up approx 0.20% of Pictet Asset Management Ltd’s portfolio.Capwealth Advisors reduced its stake in SYK by selling 750 shares or 1.53% in the most recent quarter. The Hedge Fund company now holds 48,122 shares of SYK which is valued at $5.3 Million. Stryker Corporation makes up approx 1.37% of Capwealth Advisors’s portfolio. Winton Capital Group Ltd added SYK to its portfolio by purchasing 220,350 company shares during the most recent quarter which is valued at $24.5 Million. Stryker Corporation makes up approx 0.27% of Winton Capital Group Ltd’s portfolio.Rand Wealth reduced its stake in SYK by selling 36 shares or 0.21% in the most recent quarter. The Hedge Fund company now holds 16,941 shares of SYK which is valued at $1.8 Million. Stryker Corporation makes up approx 0.25% of Rand Wealth’s portfolio.

Stryker Corporation opened for trading at $111.85 and hit $112.44 on the upside on Wednesday, eventually ending the session at $111.87, with a gain of 0.18% or 0.2 points. The heightened volatility saw the trading volume jump to 10,86,412 shares. Company has a market cap of $41,837 M.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Investors should note that on Apr 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Jun 28, 2016 as the ex-dividend date and fixed the record date on Jun 30, 2016. The payable date has been fixed on Jul 29, 2016.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.